Baked Egg or Egg Oral Immunotherapy for Children With Egg Allergy

PHASE2CompletedINTERVENTIONAL
Enrollment

92

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

September 28, 2017

Study Completion Date

September 30, 2018

Conditions
Food Allergy
Interventions
DRUG

Egg Oral Immunotherapy

Commercially available egg white solid dispensed by the central manufacturer. Study product will be dispensed in vials for low doses, capsules for mid-range doses, and bulk powder with dosing scoops for the higher doses.

DRUG

Baked Egg

Predetermined food substances with known amounts of Baked Egg (egg protein) with standardized dosing/consumption instructions.

Trial Locations (5)

21287

Johns Hopkins University, Baltimore

27599

University of North Carolina - Chapel Hill, Chapel Hill

72202

Arkansas Children's Hospital, Little Rock

80206

National Jewish Health, Denver

100029

Icahn School of Medicine at Mount Sinai, New York

Sponsors
All Listed Sponsors
collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

collaborator

Consortium of Food Allergy Research

OTHER

lead

Hugh A Sampson, MD

OTHER